{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T06:14:30Z","timestamp":1778739270911,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T00:00:00Z","timestamp":1717977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008247","name":"University of Otago","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008247","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020955","name":"GlaxoSmithKline Biologicals","doi-asserted-by":"publisher","award":["217002"],"award-info":[{"award-number":["217002"]}],"id":[{"id":"10.13039\/100020955","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.vaccine.2024.06.016","type":"journal-article","created":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T08:48:42Z","timestamp":1719046122000},"page":"126048","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Pertussis epidemiology in adults: Retrospective analysis of pertussis incidence and association with comorbidities among adult populations in Aotearoa New Zealand, using national administrative datasets"],"prefix":"10.1016","volume":"42","author":[{"given":"Adrian","family":"Howard Ludlam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8833-4501","authenticated-orcid":false,"given":"Janine","family":"Paynter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felicity","family":"Goodyear-Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Petousis-Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.06.016_b0005","first-page":"433","article-title":"Pertussis vaccines: WHO position paper - August 2015","volume":"35","author":"World Health Organisation","year":"2015","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2024.06.016_b0010","unstructured":"Immunisation Handbook. Wellington, New Zealand: Health New Zealand | Te Whatu Ora; 2024. Available from: https:\/\/www.tewhatuora.govt.nz\/for-the-health-sector\/vaccine-information\/immunisation-handbook-2024-version-1#immunisation-handbook-2024-version-1 [accessed 05 April 2024]."},{"key":"10.1016\/j.vaccine.2024.06.016_b0015","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1080\/21645515.2016.1259780","article-title":"Immune persistence after pertussis vaccination","volume":"13","author":"Chen","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2024.06.016_b0020","first-page":"283","article-title":"The pertussis enigma: reconciling epidemiology, immunology and evolution","author":"Domenech de Celles","year":"2016","journal-title":"Proc Biol Sci"},{"key":"10.1016\/j.vaccine.2024.06.016_b0025","unstructured":"World Health Organisation SAGE pertussis working group. Background Paper. Geneva, Switzerland: WHO SAGE pertussis working group; 2014. Available from: https:\/\/www.who.int\/immunization\/sage\/meetings\/2014\/april\/1_Pertussis_background_FINAL4_web.pdf?ua= [accessed 05 April 2024]."},{"key":"10.1016\/j.vaccine.2024.06.016_b0030","doi-asserted-by":"crossref","first-page":"e83850","DOI":"10.1371\/journal.pone.0083850","article-title":"Estimation of the underlying burden of pertussis in adolescents and adults in Southern Ontario","volume":"8","author":"McGirr","year":"2013","journal-title":"Canada PloS one"},{"key":"10.1016\/j.vaccine.2024.06.016_b0035","first-page":"319","article-title":"The past, present, and future of pertussis. The role of adults in epidemiology and future control","volume":"150","author":"Cherry","year":"1989","journal-title":"West J Med"},{"key":"10.1016\/j.vaccine.2024.06.016_b0040","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S1473-3099(02)00452-8","article-title":"Pertussis of adults and infants","volume":"2","author":"von Konig","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2024.06.016_b0045","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1073\/pnas.1314688110","article-title":"Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model","volume":"111","author":"Warfel","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2024.06.016_b0050","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1097\/01.inf.0000160708.43944.99","article-title":"Epidemiology of pertussis","volume":"24","author":"Tan","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2024.06.016_b0055","series-title":"Porirua","first-page":"2019","author":"ESR Pertussis Report","year":"2019"},{"key":"10.1016\/j.vaccine.2024.06.016_b0060","unstructured":"Renewed calls for people to know the symptoms of whooping cough and be immunised following third death. Wellington, NZ: Te Whatu Ora | Health New Zealand; 2023."},{"key":"10.1016\/j.vaccine.2024.06.016_b0065","first-page":"2 .7-4.5","article-title":"Pertussis (whooping cough) epidemiology in Waikato, New Zealand: 2000\u20132009","volume":"1","author":"Wall","year":"2011","journal-title":"N Z Med J"},{"key":"10.1016\/j.vaccine.2024.06.016_b0070","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/14760584.2019.1588727","article-title":"The burden of pertussis in older adults: what is the role of vaccination? A systematic literature review","volume":"18","author":"Kandeil","year":"2019","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2024.06.016_b0075","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2147\/COPD.S32330","article-title":"Epidemiology of chronic obstructive pulmonary disease: a literature review","volume":"7","author":"Rycroft","year":"2012","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.vaccine.2024.06.016_b0080","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3346\/jkms.2005.20.2.225","article-title":"Seroprevalence of Mycoplasma pneumoniae and Chlamydia pneumoniae in stable asthma and chronic obstructive pulmonary disease","volume":"20","author":"Park","year":"2005","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.vaccine.2024.06.016_b0085","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s15010-005-4004-9","article-title":"The role of Bordetella infections in patients with acute exacerbation of chronic bronchitis","volume":"33","author":"Bonhoeffer","year":"2005","journal-title":"Infection"},{"key":"10.1016\/j.vaccine.2024.06.016_b0090","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1017\/S0950268817000887","article-title":"Economic burden of diagnosed pertussis among individuals with asthma or chronic obstructive pulmonary disease in the USA: an analysis of administrative claims","volume":"145","author":"Buck","year":"2017","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2024.06.016_b0095","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/cid\/ciy889","article-title":"Severe pertussis infections in the United States, 2011\u20132015","volume":"69","author":"Mbayei","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.06.016_b0100","series-title":"Pertussis infections in hospitalized patients\u2014United States, 2010\u20132014","first-page":"1752","author":"Meyer","year":"2016"},{"key":"10.1016\/j.vaccine.2024.06.016_b0105","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/1753-6405.12781","article-title":"Constructing whole of population cohorts for health and social research using the New Zealand Integrated Data Infrastructure","volume":"42","author":"Zhao","year":"2018","journal-title":"Aust N Z J Public Health"},{"key":"10.1016\/j.vaccine.2024.06.016_b0110","series-title":"NZDep2018 Index of Deprivation: Final Research Report, December 2020","author":"Atkinson","year":"2019"},{"key":"10.1016\/j.vaccine.2024.06.016_b0115","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jclinepi.2017.08.005","article-title":"The new measuring multimorbidity index predicted mortality better than Charlson and Elixhauser indices among the general population","volume":"92","author":"Stanley","year":"2017","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.vaccine.2024.06.016_b0120","doi-asserted-by":"crossref","first-page":"e573","DOI":"10.3399\/bjgp13X670705","article-title":"When is acute persistent cough in school-age children and adults whooping cough? A prospective case series study","volume":"63","author":"Philipson","year":"2013","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.vaccine.2024.06.016_b0125","first-page":"52","article-title":"Service planning implications of estimating Primary Health Organisation enrolment rate based on a Health Service Utilisation population rather than a Census-derived population","volume":"128","author":"Chan","year":"2015","journal-title":"N Z Med J"},{"key":"10.1016\/j.vaccine.2024.06.016_b0130","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.vaccine.2016.11.004","article-title":"Age-specific effectiveness following each dose of acellular pertussis vaccine among infants and children in New Zealand","volume":"35","author":"Radke","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.06.016_b0135","unstructured":"Te R\u014dp\u016b Arotake Auau Mate o te Hunga Tamariki, Taiohi | Child and Youth Mortality Review Committee. 2021. Wellington, NZ: Health Quality & Safety Commission; 2021. Available from: https:\/\/www.hqsc.govt.nz\/assets\/Our-work\/Mortality-review-committee\/CYMRC\/Publications-resources\/CYMRC-15th-data-report2015-19_final_2.pdf [accessed 05 April 2024]."},{"key":"10.1016\/j.vaccine.2024.06.016_b0140","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1046\/j.1365-2222.2003.01598.x","article-title":"Familial and environmental determinants for wheezing and asthma in a case-control study of school children in Palestine","volume":"33","author":"El-Sharif","year":"2003","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.vaccine.2024.06.016_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/JAA.S3844","article-title":"Risk factors for asthma and allergic diseases in school children across Lebanon","volume":"2","author":"Waked","year":"2008","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.vaccine.2024.06.016_b0150","first-page":"314 -","article-title":"Risk factors for childhood asthma in Croatia","volume":"65","author":"Aberle","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.vaccine.2024.06.016_b0155","doi-asserted-by":"crossref","first-page":"8275","DOI":"10.1016\/j.vaccine.2011.08.112","article-title":"Pertussis in infancy and the association with respiratory and cognitive disorders at toddler age","volume":"29","author":"de Greeff","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.06.016_b0160","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00001648-199911000-00009","article-title":"Family size, infections, and asthma prevalence in New Zealand children","volume":"10","author":"Wickens","year":"1999","journal-title":"Epidemiology"},{"key":"10.1016\/j.vaccine.2024.06.016_b0165","doi-asserted-by":"crossref","unstructured":"Choi JH, Correia de Sousa J, Fletcher M, Gabutti G, Harrington L, Holden M, et al. Improving vaccination rates in older adults and at-risk groups: focus on pertussis. 2022.","DOI":"10.1007\/s40520-021-02018-3"},{"key":"10.1016\/j.vaccine.2024.06.016_b0170","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/15412555.2021.1899155","article-title":"Burden of Pertussis in COPD: A Retrospective Database Study in England","volume":"18","author":"Aris","year":"2021","journal-title":"COPD: J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.vaccine.2024.06.016_b0175","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1080\/15412555.2021.1920904","article-title":"Seroprevalence of Bordetella pertussis Infection in Patients With Chronic Obstructive Pulmonary Disease in England: Analysis of the AERIS Cohort","volume":"18","author":"Wilkinson","year":"2021","journal-title":"COPD: J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.vaccine.2024.06.016_b0180","doi-asserted-by":"crossref","first-page":"5647","DOI":"10.1016\/j.vaccine.2015.08.068","article-title":"Risk factors for pertussis hospitalizations in Australians aged 45 years and over: a population based nested case\u2013control study","volume":"33","author":"Karki","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.06.016_b0185","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/cid\/cis627","article-title":"Pertussis in older adults: prospective study of risk factors and morbidity","volume":"55","author":"Liu","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.06.016_b0190","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1086\/315648","article-title":"Morbidity of pertussis in adolescents and adults","volume":"182","author":"De Serres","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.06.016_b0195","first-page":"172","article-title":"High seroprevalence of Bordetella pertussis in patients with chronic obstructive pulmonary disease: a case-control study","volume":"14","author":"Hashemi","year":"2015","journal-title":"Tanaffos"},{"key":"10.1016\/j.vaccine.2024.06.016_b0200","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jaci.2011.11.020","article-title":"Increased risk of pertussis in patients with asthma","volume":"129","author":"Capili","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2024.06.016_b0205","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s40121-021-00465-z","article-title":"Pertussis in Individuals with Co-morbidities: A Systematic Review","volume":"10","author":"Macina","year":"2021","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.vaccine.2024.06.016_b0210","doi-asserted-by":"crossref","unstructured":"Blasi F, Bonanni P, Braido F, Gabutti G, Marchetti F, Centanni S. The unmet need for pertussis prevention in patients with chronic obstructive pulmonary disease in the Italian context. 2020.","DOI":"10.1080\/21645515.2019.1652517"},{"key":"10.1016\/j.vaccine.2024.06.016_b0215","unstructured":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Global Initiative for Chronic Obstructive Lung Disease; 2024. Available from: https:\/\/goldcopd.org\/2024-gold-report\/ [accessed 05 April 2024]."},{"key":"10.1016\/j.vaccine.2024.06.016_b0220","unstructured":"Recommended Vaccines for Adults: Lung Disease (including asthma or COPD). Centers for Disease Control and Prevention; 2024. Available from: https:\/\/www.cdc.gov\/vaccines\/adults\/rec-vac\/index.html [accessed 05 April 2024]."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24006753?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24006753?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T05:48:32Z","timestamp":1778737712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24006753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":44,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0264410X24006753"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.06.016","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pertussis epidemiology in adults: Retrospective analysis of pertussis incidence and association with comorbidities among adult populations in Aotearoa New Zealand, using national administrative datasets","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.06.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126048"}}